4//SEC Filing
Smith Alan K. 4
Accession 0001358403-19-000006
CIK 0001358403other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:01 PM ET
Size
17.1 KB
Accession
0001358403-19-000006
Insider Transaction Report
Form 4
Smith Alan K.
EVP, Technical Oprations
Transactions
- Exercise/Conversion
Common Stock
2019-01-02+2,344→ 4,431 total - Tax Payment
Common Stock
2019-01-02$3.33/sh−883$2,940→ 3,548 total - Exercise/Conversion
Common Stock
2019-01-03+1,562→ 5,110 total - Tax Payment
Common Stock
2019-01-03$3.20/sh−589$1,885→ 4,521 total - Exercise/Conversion
Restricted Stock Units
2019-01-02−2,344→ 7,031 total→ Common Stock (2,344 underlying) - Exercise/Conversion
Restricted Stock Units
2019-01-03−1,562→ 3,125 total→ Common Stock (1,562 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer common stock.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on January 2, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 2, 2018 for 9,375 shares.
- [F3]Represents the number of shares withheld by and surrendered to the Issuer on January 3, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 3, 2017 for 6,250 shares.
- [F4]The RSUs vest in four equal annual installments beginning on January 2, 2019.
- [F5]The RSUs vest in four equal annual installments beginning on January 3, 2018.
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001705246
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:01 PM ET
- Size
- 17.1 KB